Oncurie

Raleigh, United States

Oncurie focuses on creating the technology to deliver radionuclides selectively to metastatic tissue to treat metastatic cancer.

$75K raised

Sep 2022

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Oncurie raised?

Oncurie has raised $75K in total funding. The most recent round was Grant. The last funding was announced in September 2022.

Who are Oncurie's investors?

Oncurie's investors include National Science Foundation, One North Carolina Small Business Program.

Where is Oncurie headquartered?

Oncurie is headquartered in Raleigh, United States.

What does Oncurie do?

Oncurie focuses on creating the technology to deliver radionuclides selectively to metastatic tissue to treat metastatic cancer.

What stage is Oncurie at?

Oncurie is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 22, 2022.

MLA

"Oncurie — Funding & Investors." VCBacked, September 22, 2022, https://www.vcbacked.co/company/oncurie. Accessed July 1, 2026.

APA

VCBacked. (2022). Oncurie — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/oncurie

Wikipedia (cite web)

{{cite web |title=Oncurie — Funding & Investors |url=https://www.vcbacked.co/company/oncurie |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 22, 2022.